[Clinical usefulness of CA M26 and CA M29 in breast carcinoma].
Quaranta
M
M
U.O. Laboratorio di Analisi, Istituto Scientifico Oncologico, Bari, Italy.
Micelli
G
G
Coviello
M
M
Donadeo
A
A
Lozupone
A
A
Schittulli
F
F
D000951:Antigens, Neoplasm / Q000097:blood*; D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor / Q000097:blood*; D001943:Breast Neoplasms / Q000097:blood*; D005260:Female; D006801:Humans; D008875:Middle Aged
D000951:Antigens, Neoplasm; D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor; C057387:mucinous carcinoma-associated antigen
Utilità clinica del CA M26 e CA M29 nel carcinoma della mammella.